naion glp-1 Sight Unseen: Glucagon-Like Peptide-1 (GLP-1) Agonism Therapy and Nonarteritic Anterior Ischemic Optic Neuropathy GLP-1 Medications and NAION: What
Description
Evidence-based studies reveal that GLP-1 medications trigger receptors in your brain, effectively managing appetite and food intake
A large Swedish study published in 2018 analysed over 100,000 patients and found no association between GLP-1 receptor agonist use and pancreatic cancer
Report any eye symptoms immediately
30 Semaglutide A systematic review and meta-analysis of injectable or oral semaglutide for type 2 diabetes mellitus found no evidence of increased incidence of acute pancreatitis
